104 related articles for article (PubMed ID: 31134671)
1. Extraction of molecular features for the drug discovery targeting protein-protein interaction of Helicobacter pylori CagA and tumor suppressor protein ASSP2.
Junaid M; Li CD; Shah M; Khan A; Guo H; Wei DQ
Proteins; 2019 Oct; 87(10):837-849. PubMed ID: 31134671
[TBL] [Abstract][Full Text] [Related]
2. Structural-dynamic insights into the
Junaid M; Shah M; Khan A; Li CD; Khan MT; Kaushik AC; Ali A; Mehmood A; Nangraj AS; Choi S; Wei DQ
J Biomol Struct Dyn; 2019 Sep; 37(15):4035-4050. PubMed ID: 30328798
[No Abstract] [Full Text] [Related]
3. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2.
Nešić D; Buti L; Lu X; Stebbins CE
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1562-7. PubMed ID: 24474782
[TBL] [Abstract][Full Text] [Related]
4. An Intrinsically Disordered Region in the Proapoptotic ASPP2 Protein Binds to the Helicobacter pylori Oncoprotein CagA.
Reingewertz TH; Iosub-Amir A; Bonsor DA; Mayer G; Amartely H; Friedler A; Sundberg EJ
Biochemistry; 2015 Jun; 54(21):3337-47. PubMed ID: 25963096
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular energies of the cytotoxic protein CagA of Helicobacter pylori as a possible descriptor of strains' pathogenicity level.
Rojas-Rengifo DF; Alvarez-Silva MC; Ulloa-Guerrero CP; Nuñez-Velez VL; Del Pilar Delgado M; Aguilera SM; Castro H; Jaramillo CA; Fernando González Barrios A
Comput Biol Chem; 2018 Oct; 76():17-22. PubMed ID: 29864542
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation.
Tsang YH; Lamb A; Romero-Gallo J; Huang B; Ito K; Peek RM; Ito Y; Chen LF
Oncogene; 2010 Oct; 29(41):5643-50. PubMed ID: 20676134
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host.
Buti L; Spooner E; Van der Veen AG; Rappuoli R; Covacci A; Ploegh HL
Proc Natl Acad Sci U S A; 2011 May; 108(22):9238-43. PubMed ID: 21562218
[TBL] [Abstract][Full Text] [Related]
8. H. pylori-encoded CagA disrupts tight junctions and induces invasiveness of AGS gastric carcinoma cells via Cdx2-dependent targeting of Claudin-2.
Song X; Chen HX; Wang XY; Deng XY; Xi YX; He Q; Peng TL; Chen J; Chen W; Wong BC; Chen MH
Cell Immunol; 2013; 286(1-2):22-30. PubMed ID: 24287273
[TBL] [Abstract][Full Text] [Related]
9. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate.
Hashi K; Imai C; Yahara K; Tahmina K; Hayashi T; Azuma T; Miyabe-Nishiwaki T; Sato H; Matsuoka M; Niimi S; Okamoto M; Hatakeyama M
Sci Rep; 2018 Oct; 8(1):15981. PubMed ID: 30374120
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.
Lind J; Backert S; Hoffmann R; Eichler J; Yamaoka Y; Perez-Perez GI; Torres J; Sticht H; Tegtmeyer N
BMC Microbiol; 2016 Sep; 16(1):201. PubMed ID: 27590005
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.
Fujii Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin.
Kaplan-Türköz B; Jiménez-Soto LF; Dian C; Ertl C; Remaut H; Louche A; Tosi T; Haas R; Terradot L
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14640-5. PubMed ID: 22908298
[TBL] [Abstract][Full Text] [Related]
14. Predictive profiling of gram-negative antibiotics in CagA oncoprotein inactivation: a molecular dynamics simulation approach.
Varshney N; Kashyap D; Behra SK; Saini V; Chaurasia A; Kumar S; Jha HC
SAR QSAR Environ Res; 2023; 34(6):501-521. PubMed ID: 37462112
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.
Zhang BG; Hu L; Zang MD; Wang HX; Zhao W; Li JF; Su LP; Shao Z; Zhao X; Zhu ZG; Yan M; Liu B
Oncotarget; 2016 Mar; 7(9):9788-800. PubMed ID: 26848521
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.
Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS
J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607
[TBL] [Abstract][Full Text] [Related]
18. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori cytotoxin-associated gene A protein upregulates α-enolase expression via Src/MEK/ERK pathway: implication for progression of gastric cancer.
Chen S; Duan G; Zhang R; Fan Q
Int J Oncol; 2014 Aug; 45(2):764-70. PubMed ID: 24841372
[TBL] [Abstract][Full Text] [Related]
20. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
